Ayman Semaan | Head of Market Access & Pricing
Biologix

Ayman Semaan | Market Access & Pricing Lead | Pharma & Life Sciences Expert Ayman Semaan is a Market Access & Pricing Lead with 20 years in the life sciences industry, including over a decade dedicated to pharmaceutical pricing strategy and access policy across the Levant, Gulf, and North Africa. He has shaped and delivered end-to-end pricing archetypes; spanning list, net, and tender price strategies, and pioneered Value-Based Agreements for highly specialized and rare disease therapies, establishing new benchmarks for how manufacturers and payers negotiate access across MENA markets. A recognized thought leader at the intersection of pricing, health economics, and access policies, Ayman brings sharp, up-to-date fluency in evolving reimbursement landscapes across heterogeneous market environments. He is a sought-after voice at global and regional life sciences forums, a member of the HTAi Rare Diseases Working Group, and a former Board Member of ISPOR Lebanon Chapter. He holds a Master’s in Health Sciences from the Lebanese University and Grenoble Alpes University.